[Clostridium difficile infections - still a major challenge]

MMW Fortschr Med. 2013 Apr 18;155(7):57-9. doi: 10.1007/s15006-013-0436-9.
[Article in German]
No abstract available

MeSH terms

  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides difficile* / pathogenicity
  • Colectomy
  • Combined Modality Therapy
  • Cross Infection / diagnosis
  • Cross Infection / therapy
  • Disease Notification
  • Enterocolitis, Pseudomembranous / diagnosis*
  • Enterocolitis, Pseudomembranous / therapy
  • Fidaxomicin
  • Metronidazole / therapeutic use
  • Probiotics / therapeutic use
  • Vancomycin / therapeutic use
  • Virulence

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Metronidazole
  • Vancomycin
  • Fidaxomicin